SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-013906
Filing Date
2018-12-14
Accepted
2018-12-14 18:15:14
Documents
2
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2873
2 POWER-OF-ATTORNEY poaoler.txt EX-24 3713
  Complete submission text file 0001179110-18-013906.txt   8142
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPECTRUM PHARMACEUTICALS 11500 SOUTH EASTERN AVENUE, SUITE 240 HENDERSON NV 89052
Business Address
OLER ABRAHAM N. (Reporting) CIK: 0001557372 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 181236585